Equate Advance Anti-oxidant
Natural health product licensed in Canada
- Other names
- Dr Nutrition Equate Advance Anti-oxidant, MapleLife Nutrition Equate Advance Anti-oxidant, Nutralab Canada Equate Advance Anti-oxidant
- Licence holder
- Maplelife Nutrition Corporation
- NPN or DIN-HM
- 80060523
- Status
- Active licence
- Licence date
- 4 May 2015
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine C: up to 500 mg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 180 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Zinc: up to 50 mg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 15 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- À vérifier
Zinc: up to 50 mg a day according to the dosing instructions published by Health Canada, above the limite de sécurité from EFSAEuropean Food Safety Authority. for adults (25 mg a day). Le repère de l'EFSA porte sur l'apport total d'une journée, alimentation et compléments.
limite supérieure de sécurité (UL). EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| (3R,3'R,6'R)-bêta,epsilon-carotène-3,3'-diol Source : Lutéine(USP) | 5 milligramme | Not calculated |
| Bêta-carotene-3,3'-diol totalement trans- Source : Zeaxanthin | 1 milligramme | Not calculated |
| Cuivre Source : Citrate cuivrique | 1 milligramme | 2,000 µg |
| Vitamine C Source : Vitamine C | 250 milligramme | 500,000 µg |
| Vitamine E Source : Acétate de dl-alpha tocophéryle Potency : 200 UI | 134 mg AT | Not calculated |
| Zinc Source : Oxyde de zinc | 25 milligramme | 50,000 µg |
Non-medicinal ingredients
Hydroxypropylcellulose, Poly(sorbate) 80, Cire de Carnauba, Ethylvanilline, Monoglycérides diacétylatés, Caramel, Cellulose microcristalline, Stéarate de magnésium, Acide stéarique, Gomme de xanthane, Eau purifiée, Dioxyde de titane, Silicate de calcium, Poly(éthylène glycol), Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 2 Comprimé | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps in the development and maintenance of bones, cartilage, teeth and gum. An antioxidant for the maintenance of good health. Helps the body to metabolize carbohydrates, fats and proteins. Helps to maintain immune function. Helps to maintain eyesight in conditions (associated with sunlight damage), such as cataracts and age-related macular degeneration. Helps to reduce the risk of developing cataracts. Helps to improve macular pigment optical density.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Do not use if you are allergic to plants of the Asteraceae/Compositae/Daisy family.
Source
Official Health Canada record, licence 80060523
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.